Trillium Therapeutics Inc. announced the appointment of Mr. Jan Skvarka as President and Chief Executive Officer effective September 25, 2019. Mr. Skvarka has also been appointed to the Board of Directors of the company. Before joining Trillium, Mr. Skvarka was President and Chief Executive Officer of Tal Medical, a clinical-stage neuroscience company in Boston, Massachusetts, from 2014 until 2018.

Prior to that he had a long career from 1999 to 2013 as a healthcare consultant at Bain & Company, Boston. He was a partner in the Bain Healthcare practice from 2007 until 2013, with a focus on pharmaceutical, biotechnology and medical technology companies. Earlier in his career he worked in the corporate finance arm of Price Waterhouse in London, UK and Vienna, Austria.

Mr. Skvarka holds an MBA degree from Harvard Business School.